Jianfeng Shen Selected Research

Jianfeng Shen Research Topics

Disease

26	Neoplasms (Cancer) 05/2024 - 01/2010
4	Bites and Stings (Sting) 01/2024 - 01/2019
4	Carcinogenesis 01/2023 - 02/2013
4	Genomic Instability 01/2023 - 01/2021
3	Uveal melanoma 12/2023 - 01/2023
2	Postoperative Pain 02/2023 - 01/2019
2	Hematoma 01/2019 - 08/2008
2	Stomach Neoplasms (Stomach Cancer) 06/2018 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2018
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2011 - 01/2010
1	COVID-19 01/2023
1	Fatigue 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020
1	Adenocarcinoma of Lung 12/2020
1	Hernia (Hernias) 01/2019
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Seroma 01/2019
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2014
1	Neoplasm Metastasis (Metastasis) 02/2013
1	Gliosis 01/2011

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2008
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	InterferonsIBA 01/2024 - 01/2023
3	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 01/2019
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 07/2015
2	EnzymesIBA 01/2022 - 01/2020
2	ChromatinIBA 04/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 11/2020 - 12/2014
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2016 - 02/2013
1	SiliconIBA 05/2024
1	Hyaluronic Acid (Hyaluronan)IBA 05/2024
1	AcidsIBA 05/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	polydopamineIBA 05/2024
1	Retinoblastoma ProteinIBA 03/2024
1	E2F Transcription FactorsIBA 03/2024
1	Interferon Type IIBA 01/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024
1	NucleotidesIBA 12/2023
1	MetalsIBA 01/2023
1	IonsIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	CytosineIBA 01/2023
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2023
1	selamectinIBA 01/2023
1	ThymineIBA 01/2023
1	LigandsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	APOBEC-1 DeaminaseIBA 01/2023
1	Cytidine DeaminaseIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	TegafurIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	tislelizumabIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	gimeracilIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	HeliumIBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	TubulinIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	Verteporfin (Visudyne)FDA Link 01/2020
1	AntibodiesIBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	tetraethylpyrazine (TEP)IBA 01/2019
1	Histone-Lysine N-MethyltransferaseIBA 06/2018
1	Cadherins (E-Cadherin)IBA 06/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	nucleoside diphosphate kinase 2IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Nerve Growth Factors (Neurotrophins)IBA 01/2011
1	CytokinesIBA 01/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2010
1	Hypoxia-Inducible Factor 1IBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010

Therapy/Procedure

15	Therapeutics 05/2024 - 08/2006
4	Immunotherapy 12/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 05/2024 - 01/2022
1	Photothermal Therapy 05/2024
1	Operative Surgical Procedures 02/2023
1	Neoadjuvant Therapy 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Herniorrhaphy 01/2019
1	Surgical Instruments (Clip) 01/2019
1	Length of Stay 01/2019
1	Operative Time 01/2019
1	Radiotherapy 12/2017